← 產業報告目錄

Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (On-premises, Cloud-based), Technology (Superconducting Qubits, Trapped Ions), Application (Drug Discovery, Genomics), End User, and Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-07-09頁數 294報告編號 HIT8642

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global quantum computing in healthcare market is projected to reach USD 1,324.2 million by 2030 from USD 265.9 million in 2025 at a high CAGR of 37.9% during the forecast period. The quantum computing market in healthcare is steadily advancing due to the pressing need to improve drug discovery, enhance clinical decision-making, and increase diagnostic accuracy. As healthcare data becomes more complex and voluminous, quantum computing offers powerful tools for simulation, modeling, and advanced data processing that surpass traditional systems. These solutions are expected to significantly reduce research timelines and costs while also facilitating the development of more targeted and personalized treatments. The growth of this market is further supported by increasing funding for quantum startups, government-backed research initiatives, and collaborative efforts between academia and industry. However, the sector faces challenges, particularly regarding the accuracy of quantum systems and the high costs associated with their implementation, which continue to hinder widespread adoption. “The superconducting qubits segment is expected to be the largest segment during the forecast period.” In 2024, superconducting qubits emerged as the largest segment in the quantum computing market for healthcare and are expected to maintain this position in the coming years. This dominance is driven by their maturity, scalability potential, and strong performance in executing complex computational tasks. Superconducting qubit systems offer high-speed processing capabilities, making them well-suited for healthcare applications such as molecular simulations, genomic analysis, and drug discovery. These systems are also compatible with cloud-based quantum platforms, allowing researchers and clinicians broader access without the need for extensive on-premises infrastructure. As the demand for more efficient tools to handle biomedical data and accurately model biological systems grows, superconducting qubit technology is increasingly being adopted in healthcare-focused quantum initiatives. Continued advancements in coherence times, error correction, and integration with hybrid computing frameworks further reinforce their role as a foundational technology for accelerating innovation in healthcare. “Healthcare payers are expected to be the fastest-growing segment in the quantum computing in healthcare market, by end user, during the forecast period.” Healthcare payers have emerged as the fastest-growing end-user group in the quantum computing in healthcare market. This trend is driven by the increasing need for advanced data processing tools to manage healthcare costs, assess patient risks, and support personalized coverage plans. Quantum computing enables quicker analysis of complex datasets, allowing payers to enhance risk prediction, detect anomalies, and develop value-based reimbursement models. As the healthcare industry shifts toward data-driven decision-making, payers are adopting quantum technologies to improve operational efficiency, reduce fraud, and gain deeper insights into treatment outcomes and population health. “Asia Pacific is expected to witness the highest growth rate during the forecast period.” The Asia Pacific region is projected to experience the fastest growth in the quantum computing in healthcare market during the forecast period. This growth is driven by increasing government support for quantum technology, a rise in research collaborations, and a surge in funding for emerging tech startups. Countries in the region are prioritizing quantum innovation through national strategies and investments, establishing a strong foundation for the application of these technologies in healthcare. As the burden of chronic diseases grows, there is an increased focus on utilizing quantum computing for tasks such as drug research, genetic analysis, and complex data modeling. Additionally, enhanced digital infrastructure and wider access to cloud-based quantum platforms are facilitating faster adoption. Collectively, these factors are positioning Asia Pacific as a key hub for advancements in quantum healthcare. The breakdown of primary participants is as mentioned below: • By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%) • By Designation: Directors (42%), Managers (31%), and Others (27%) • By Region: North America (32%), Europe (26%), Asia Pacific (32%), the Middle East & Africa (5%), and Latin America (5%) Key Players in the Quantum Computing in Healthcare Market The key players operating in the quantum computing in healthcare market include Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), IonQ (US), Quantinuum, Ltd. (US & UK), Google, Inc. (US), Atos SE (France), QC Ware (California), Classiq Technologies, Inc. (US), Xanadu Quantum Technologies Inc. (Canada), Hefei Origin Quantum Computing Technology Co., Ltd. (China), Protiviti, Inc. (US), Quandela (France), Deloitte (UK), Accenture (Ireland), Amazon Web Services (AWS) (US), Fujitsu (Japan), Qnami (Switzerland), SEEQC (US), SandboxAQ (US), Pasqal (France), Qubit Pharmaceuticals (France), Polaris Quantum Biotech (US), and QSimulate (US). Research Coverage The report analyzes the quantum computing in healthcare market and estimates the market size and future growth potential of various market segments based on component, deployment, application, technology, end user, and region. It also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market. This report provides insights on:  Analysis of key drivers (increasing investments in quantum computing in developed as well as emerging economies, growing inclination of payers toward quantum computing, rising demand for personalized medicine, increasing funding and investments in quantum computing startups, and rising need to reduce time and cost of drug discovery and development), restraints (accuracy issues with quantum computing systems and high implementation costs), opportunities (technological advancements in quantum computing supporting various healthcare applications and potential applications in medical image analysis and oncology), and challenges (lack of technical expertise & data management issues) influencing the growth of the quantum computing in healthcare market.  Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the quantum computing in healthcare market.  Market Development: Comprehensive information on the lucrative emerging markets. The report analyzes the market for various types of quantum computing in healthcare solutions across regions.  Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the quantum computing in healthcare market.  Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the quantum computing in healthcare market, like Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), and IonQ (US).
目錄 Table of Contents
1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.3 STUDY SCOPE 29 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 29 1.3.2 YEARS CONSIDERED 31 1.4 CURRENCY CONSIDERED 31 1.5 STAKEHOLDERS 32 1.6 LIMITATIONS 32 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH APPROACH 33 2.1.1 SECONDARY RESEARCH 34 2.1.1.1 Key data from secondary sources 35 2.1.2 PRIMARY RESEARCH 35 2.1.2.1 Primary sources 36 2.1.2.2 Key data from primary sources 37 2.1.2.3 Breakdown of primaries 37 2.1.2.4 Insights from primary experts 38 2.2 RESEARCH METHODOLOGY DESIGN 38 2.3 MARKET SIZE ESTIMATION 40 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 44 2.5 MARKET SHARE ESTIMATION 44 2.6 STUDY ASSUMPTIONS 45 2.7 RESEARCH LIMITATIONS 45 2.7.1 METHODOLOGY-RELATED LIMITATIONS 45 2.8 RISK ASSESSMENT 45 3 EXECUTIVE SUMMARY 46 4 PREMIUM INSIGHTS 51 4.1 OVERVIEW OF QUANTUM COMPUTING IN HEALTHCARE MARKET 51 4.2 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT 52 4.3 GEOGRAPHIC SNAPSHOT OF QUANTUM COMPUTING IN HEALTHCARE MARKET 53 4.4 REGIONAL MIX: QUANTUM COMPUTING IN HEALTHCARE MARKET 54 4.5 QUANTUM COMPUTING IN HEALTHCARE MARKET: DEVELOPED VS. EMERGING ECONOMIES 54   5 MARKET OVERVIEW 55 5.1 INTRODUCTION 55 5.2 MARKET DYNAMICS 55 5.2.1 MARKET DRIVERS 56 5.2.1.1 Increasing investments in quantum computing in developed as well as emerging economies 56 5.2.1.2 Growing inclination of payers toward quantum computing 57 5.2.1.3 Rising demand for personalized medicine 58 5.2.1.4 Increasing funding and investments in quantum computing startups 59 5.2.1.5 Rising need to reduce time and cost of drug discovery and development 60 5.2.2 MARKET RESTRAINTS 61 5.2.2.1 Accuracy issues with quantum computing systems and high implementation costs 61 5.2.3 MARKET OPPORTUNITIES 62 5.2.3.1 Technological advancements in quantum computing for various healthcare applications 62 5.2.3.2 Potential applications in medical image analysis and oncology 62 5.2.4 MARKET CHALLENGES 63 5.2.4.1 Lack of technical expertise and data management issues 63 5.3 INDUSTRY TRENDS 63 5.3.1 HYBRID QUANTUM-CLASSICAL COMPUTING 63 5.3.2 QUANTUM MACHINE LEARNING 64 5.3.3 GROWING NUMBER OF APPLICATIONS IN HEALTHCARE INDUSTRY 65 5.4 TECHNOLOGY ANALYSIS 66 5.4.1 KEY TECHNOLOGIES 66 5.4.1.1 Artificial intelligence and machine learning integration 66 5.4.1.2 Quantum communication technology 67 5.4.2 COMPLEMENTARY TECHNOLOGIES 67 5.4.2.1 Blockchain 67 5.4.2.2 Digital twins 67 5.4.3 ADJACENT TECHNOLOGIES 68 5.4.3.1 Precision medicine 68 5.5 PORTER’S FIVE FORCES ANALYSIS 68 5.5.1 INTENSITY OF COMPETITIVE RIVALRY 69 5.5.2 BARGAINING POWER OF SUPPLIERS 70 5.5.3 BARGAINING POWER OF BUYERS 70 5.5.4 THREAT OF NEW ENTRANTS 70 5.5.5 THREAT OF SUBSTITUTES 70   5.6 REGULATORY ANALYSIS 71 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 5.6.2 REGULATORY STANDARDS 73 5.6.2.1 P1913 – Software-defined quantum communication 73 5.6.2.2 P7130 – Standard for quantum technologies definitions 73 5.6.2.3 P7131 – Standard for quantum computing performance metrics and benchmarking 73 5.7 VALUE CHAIN ANALYSIS 74 5.7.1 RESEARCH, DESIGN, AND DEVELOPMENT 74 5.7.2 MANUFACTURERS & SERVICE PROVIDERS 74 5.7.3 MARKETING & SALES EXECUTIVES 74 5.7.4 END USERS 75 5.8 ECOSYSTEM ANALYSIS 75 5.9 PATENT ANALYSIS 76 5.9.1 PATENT PUBLICATION TRENDS QUANTUM COMPUTING IN HEALTHCARE MARKET 76 5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 77 5.10 CASE STUDY ANALYSIS 79 5.11 KEY STAKEHOLDERS & BUYING CRITERIA 80 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 80 5.11.2 BUYING CRITERIA 81 5.12 KEY CONFERENCES & EVENTS (2025–2026) 82 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83 5.14 IMPACT OF 2025 US TARIFF ON QUANTUM COMPUTING IN HEALTHCARE MARKET 83 5.14.1 INTRODUCTION 83 5.14.2 KEY TARIFF RATES 84 5.14.3 PRICE IMPACT ANALYSIS 85 5.14.4 IMPACT ON COUNTRY/REGION 85 5.14.4.1 US 85 5.14.4.2 Europe 86 5.14.4.3 Asia Pacific 86 5.14.5 IMPACT ON END USERS 87 5.14.5.1 Pharmaceutical & biotechnology companies 87 5.14.5.2 Labs & research institutes 87 5.14.5.3 Healthcare providers 87 5.14.5.4 Healthcare payers 88 6 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT 89 6.1 INTRODUCTION 90 6.2 SOFTWARE 90 6.2.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH 90   6.3 HARDWARE 91 6.3.1 NEED FOR FREQUENT HARDWARE UPGRADES TO DRIVE MARKET GROWTH 91 6.4 SERVICES 92 6.4.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES 92 7 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT 94 7.1 INTRODUCTION 95 7.2 ON-PREMISE SOLUTIONS 95 7.2.1 RISING DEPLOYMENT OF ON-PREMISE QUANTUM COMPUTERS BY ORGANIZATIONS TO ENSURE DATA SECURITY 95 7.3 CLOUD-BASED SOLUTIONS 96 7.3.1 INCREASING PREFERENCE FOR CLOUD-BASED QUANTUM COMPUTING FOR RESEARCH & DEVELOPMENT TO SUPPORT MARKET GROWTH 96 8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY 98 8.1 INTRODUCTION 99 8.2 SUPERCONDUCTING QUBITS 99 8.2.1 LOW POWER CONSUMPTION, HIGH SPEED, AND ABILITY TO OPERATE AT LOW TEMPERATURES TO DRIVE MARKET 99 8.3 TRAPPED IONS 100 8.3.1 SUPERIOR CONNECTIVITY AND HIGHER GATE FIDELITY TO DRIVE MARKET 100 8.4 QUANTUM ANNEALING 101 8.4.1 QUICK DISCOVERY OF MOST EFFICIENT CONFIGURATIONS AMONG POSSIBLE COMBINATIONS OF VARIABLES TO DRIVE MARKET 101 8.5 QUANTUM MACHINE LEARNING 102 8.5.1 ABILITY OF QML TO ACCELERATE HEALTHCARE INNOVATION THROUGH NEXT-GEN INTELLIGENCE TO BOOST MARKET 102 8.6 OTHER TECHNOLOGIES 103 9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION 105 9.1 INTRODUCTION 106 9.2 DRUG DISCOVERY & DEVELOPMENT 106 9.2.1 ENABLING ACCURATE DATA PROJECTIONS AND SOLUTIONS FOR DRUG DISCOVERY AND DEVELOPMENT TO BOOST MARKET GROWTH 106 9.3 MEDICAL DIAGNOSTICS 107 9.3.1 PRECISE AND SENSITIVE MEDICAL DIAGNOSTIC PROCEDURES TO DRIVE MARKET 107 9.4 GENOMICS & PRECISION MEDICINE 108 9.4.1 UNLOCKING POWER OF GENOMICS & PRECISION MEDICINE WITH QUANTUM COMPUTING TECHNOLOGY TO SUPPORT MARKET GROWTH 108 9.5 RADIOTHERAPY 109 9.5.1 MORE PERSONALIZED AND PRECISE TREATMENT IN FIGHT AGAINST CANCER TO FUEL GROWTH 109   9.6 RISK ANALYSIS 110 9.6.1 ENHANCED PRICING MODEL MANAGEMENT AND DECREASED COSTS ASSOCIATED WITH FRAUD TO BOOST ADOPTION IN RISK ANALYSIS 110 9.7 HEALTHCARE LOGISTICS & SCHEDULING 111 9.7.1 ENHANCED OPERATIONAL EFFICIENCY AND REDUCED SCHEDULING BOTTLENECKS IN HEALTHCARE DELIVERY TO DRIVE DEMAND 111 9.8 CYBERSECURITY & DATA ENCRYPTION 112 9.8.1 SECURE PATIENT DATA WITH QUANTUM-RESISTANT ENCRYPTION AND ULTRA-SAFE COMMUNICATION PROTOCOLS TO PROPEL DEMAND 112 9.9 OTHER APPLICATIONS 113 10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER 115 10.1 INTRODUCTION 116 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 116 10.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND COSTS OF DRUG DEVELOPMENT TO DRIVE GROWTH 116 10.3 LABS & RESEARCH INSTITUTES 117 10.3.1 INCREASED RESEARCH ACTIVITIES TO ENCOURAGE USE OF AI IN GENOMICS IN ACADEMIC AND GOVERNMENT INSTITUTES 117 10.4 HEALTHCARE PROVIDERS 118 10.4.1 IMPROVED PATIENT MANAGEMENT, LOWERED COSTS, AND ABILITY TO DELIVER BETTER PATIENT TREATMENT TO BOOST DEMAND 118 10.5 HEALTHCARE PAYERS 119 10.5.1 POTENTIAL TO REDUCE READMISSIONS AND OVERHEAD COSTS TO DRIVE ADOPTION 119 11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION 121 11.1 INTRODUCTION 122 11.2 NORTH AMERICA 122 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 123 11.2.2 US 126 11.2.2.1 Expanding applications of quantum computing in healthcare to bolster market growth 126 11.2.3 CANADA 129 11.2.3.1 Investments and developments in quantum computing industry to drive market 129 11.3 EUROPE 132 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 132 11.3.2 GERMANY 135 11.3.2.1 Collaborations & partnerships to drive adoption of quantum computing solutions 135 11.3.3 UK 138 11.3.3.1 Increased focus on quantum computing applications to support growth 138   11.3.4 FRANCE 141 11.3.4.1 Government funding for quantum computing to bolster growth 141 11.3.5 ITALY 143 11.3.5.1 Advances in quantum healthcare with supercomputing integration and next-gen biomedical research to boost market 143 11.3.6 SPAIN 146 11.3.6.1 Strong government support to boost market in Spain 146 11.3.7 REST OF EUROPE 148 11.4 ASIA PACIFIC 151 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 151 11.4.2 JAPAN 155 11.4.2.1 Rising penetration of technologies to support market growth 155 11.4.3 CHINA 158 11.4.3.1 China to dominate quantum computing in healthcare market in Asia Pacific 158 11.4.4 INDIA 161 11.4.4.1 Emerging real-world use cases to drive demand in India 161 11.4.5 REST OF ASIA PACIFIC 163 11.5 LATIN AMERICA 166 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 166 11.5.2 BRAZIL 169 11.5.2.1 Rising adoption of quantum technologies to drive healthcare innovation in Brazil 169 11.5.3 MEXICO 172 11.5.3.1 Mexico to pave the way for quantum healthcare innovation 172 11.5.4 REST OF LATIN AMERICA 174 11.6 MIDDLE EAST & AFRICA 177 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 177 11.6.2 GCC COUNTRIES 180 11.6.2.1 Advancing healthcare in GCC through quantum computing to drive growth 180 11.6.3 REST OF MIDDLE EAST & AFRICA 183 12 COMPETITIVE LANDSCAPE 186 12.1 OVERVIEW 186 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 186 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN QUANTUM COMPUTING IN HEALTHCARE MARKET 186 12.3 REVENUE ANALYSIS, 2020–2024 189 12.4 MARKET SHARE ANALYSIS, 2024 190 12.5 MARKET RANKING ANALYSIS 193 12.6 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2024 194 12.6.1 STARS 194 12.6.2 EMERGING LEADERS 195 12.6.3 PERVASIVE PLAYERS 195 12.6.4 PARTICIPANTS 195 12.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 197 12.6.5.1 Company footprint 197 12.6.5.2 Region footprint 198 12.6.5.3 Component footprint 199 12.6.5.4 Application footprint 200 12.6.5.5 Technology footprint 201 12.6.5.6 Deployment footprint 202 12.6.5.7 End-user footprint 203 12.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 204 12.7.1 PROGRESSIVE COMPANIES 204 12.7.2 RESPONSIVE COMPANIES 204 12.7.3 DYNAMIC COMPANIES 204 12.7.4 STARTING BLOCKS 204 12.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 206 12.7.5.1 Detailed list of key startups/SMEs 206 12.7.5.2 Competitive benchmarking of startups/SMEs 206 12.8 COMPANY VALUATION & FINANCIAL METRICS 207 12.8.1 FINANCIAL METRICS 207 12.8.2 COMPANY VALUATION 207 12.9 BRAND/SOFTWARE COMPARISON 208 12.10 COMPETITIVE SCENARIO 209 12.10.1 PRODUCT & SERVICE LAUNCHES 209 12.10.2 DEALS 210 13 COMPANY PROFILES 212 13.1 KEY PLAYERS 212 13.1.1 RIGETTI & CO, LLC. 212 13.1.1.1 Business overview 212 13.1.1.2 Products & services offered 213 13.1.1.3 Recent developments 214 13.1.1.3.1 Product launches 214 13.1.1.3.2 Deals 215 13.1.1.3.3 Other developments 216 13.1.1.4 MnM view 217 13.1.1.4.1 Key strengths 217 13.1.1.4.2 Strategic choices 217 13.1.1.4.3 Weaknesses & competitive threats 217   13.1.2 IBM 218 13.1.2.1 Business overview 218 13.1.2.2 Products & services offered 219 13.1.2.3 Recent developments 220 13.1.2.3.1 Product launches 220 13.1.2.3.2 Deals 220 13.1.2.4 MnM view 221 13.1.2.4.1 Key strengths 221 13.1.2.4.2 Strategic choices 221 13.1.2.4.3 Weaknesses & competitive threats 221 13.1.3 D-WAVE QUANTUM INC. 222 13.1.3.1 Business overview 222 13.1.3.2 Products & services offered 224 13.1.3.3 Recent developments 224 13.1.3.3.1 Product launches 224 13.1.3.3.2 Deals 225 13.1.3.4 MnM view 226 13.1.3.4.1 Key strengths 226 13.1.3.4.2 Strategic choices 226 13.1.3.4.3 Weaknesses & competitive threats 226 13.1.4 MICROSOFT 227 13.1.4.1 Business overview 227 13.1.4.2 Products & services offered 229 13.1.4.3 Recent developments 229 13.1.4.3.1 Product launches 229 13.1.4.3.2 Deals 230 13.1.4.4 MnM view 230 13.1.4.4.1 Key strengths 230 13.1.4.4.2 Strategic choices 231 13.1.4.4.3 Weaknesses & competitive threats 231 13.1.5 IONQ 232 13.1.5.1 Business overview 232 13.1.5.2 Products & services offered 233 13.1.5.3 Recent developments 234 13.1.5.3.1 Product launches 234 13.1.5.3.2 Deals 234 13.1.5.4 MnM view 235 13.1.5.4.1 Key strengths 235 13.1.5.4.2 Strategic choices 235 13.1.5.4.3 Weaknesses & competitive threats 235   13.1.6 QUANTINUUM LTD. 236 13.1.6.1 Business overview 236 13.1.6.2 Products & services offered 236 13.1.6.3 Recent developments 237 13.1.6.3.1 Product launches 237 13.1.6.3.2 Deals 238 13.1.7 GOOGLE LLC 239 13.1.7.1 Business overview 239 13.1.7.2 Products & services offered 240 13.1.7.3 Recent developments 241 13.1.7.3.1 Product launches 241 13.1.7.3.2 Deals 242 13.1.7.4 MnM view 243 13.1.7.4.1 Key strengths 243 13.1.7.4.2 Strategic choices 243 13.1.7.4.3 Weaknesses & competitive threats 243 13.1.8 ATOS SE 244 13.1.8.1 Business overview 244 13.1.8.2 Products & services offered 245 13.1.8.3 Recent developments 245 13.1.8.3.1 Product launches 245 13.1.8.3.2 Deals 246 13.1.9 QC WARE 247 13.1.9.1 Business overview 247 13.1.9.2 Products & services offered 247 13.1.9.3 Recent developments 248 13.1.9.3.1 Product launches 248 13.1.9.3.2 Deals 248 13.1.10 CLASSIQ TECHNOLOGIES LTD. 249 13.1.10.1 Business overview 249 13.1.10.2 Products & services offered 249 13.1.10.3 Recent developments 250 13.1.10.3.1 Deals 250 13.1.11 XANADU QUANTUM TECHNOLOGIES INC. 252 13.1.11.1 Business overview 252 13.1.11.2 Products & services offered 252 13.1.11.3 Recent developments 253 13.1.11.3.1 Product launches 253 13.1.11.3.2 Deals 254   13.1.12 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD. 256 13.1.12.1 Business overview 256 13.1.12.2 Products & services offered 256 13.1.12.3 Recent developments 257 13.1.12.3.1 Product launches 257 13.1.12.3.2 Deals 258 13.1.13 PROTIVITI INC. 259 13.1.13.1 Business overview 259 13.1.13.2 Products & services offered 260 13.1.14 QUANDELA 261 13.1.14.1 Business overview 261 13.1.14.2 Products & services offered 261 13.1.14.3 Recent developments 262 13.1.14.3.1 Product launches 262 13.1.14.3.2 Deals 262 13.1.15 DELOITTE 264 13.1.15.1 Business overview 264 13.1.15.2 Products & services offered 264 13.1.15.3 Recent developments 265 13.1.15.3.1 Deals 265 13.1.16 ACCENTURE 266 13.1.16.1 Business overview 266 13.1.16.2 Products & services offered 267 13.1.16.3 Recent developments 268 13.1.16.3.1 Deals 268 13.1.17 AMAZON WEB SERVICES (AWS) 269 13.1.17.1 Business overview 269 13.1.17.2 Products & services offered 270 13.1.17.3 Recent developments 271 13.1.17.3.1 Product & service launches 271 13.1.17.3.2 Deals 271 13.1.17.4 MnM view 272 13.1.17.4.1 Key strengths 272 13.1.17.4.2 Strategic choices 272 13.1.17.4.3 Weaknesses & competitive threats 272 13.1.18 FUJITSU 273 13.1.18.1 Business overview 273 13.1.18.2 Product & services offered 274 13.1.18.3 Recent developments 275 13.1.18.3.1 Product launches 275 13.1.18.3.2 Deals 276   13.1.19 QNAMI 277 13.1.19.1 Business overview 277 13.1.19.2 Products & services offered 277 13.1.19.3 Recent developments 278 13.1.19.3.1 Product launches 278 13.1.19.3.2 Deals 278 13.1.19.3.3 Expansions 278 13.1.20 SEEQC 279 13.1.20.1 Business overview 279 13.1.20.2 Product & services offered 279 13.1.20.3 Recent developments 280 13.1.20.3.1 Product launches 280 13.1.20.3.2 Deals 280 13.2 OTHER PLAYERS 281 13.2.1 SANDBOX AQ 281 13.2.2 PASQAL 281 13.2.3 QUBIT PHARMACEUTICALS 282 13.2.4 POLARIS QUANTUM BIOTECH 283 13.2.5 QSIMULATE 283 14 APPENDIX 284 14.1 DISCUSSION GUIDE 284 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 290 14.3 CUSTOMIZATION OPTIONS 292 14.4 RELATED REPORTS 292 14.5 AUTHOR DETAILS 293
圖表清單 List of Tables & Figures
TABLE 1 INCLUSIONS & EXCLUSIONS 30 TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 31 TABLE 3 RISK ASSESSMENT: QUANTUM COMPUTING IN HEALTHCARE MARKET 45 TABLE 4 MARKET DYNAMICS: QUANTUM COMPUTING IN HEALTHCARE MARKET 56 TABLE 5 LIST OF QUANTUM COMPUTING STARTUPS 59 TABLE 6 QUANTUM COMPUTING IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 69 TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 11 QUANTUM COMPUTING IN HEALTHCARE MARKET: LIST OF PATENTS/ PATENT APPLICATIONS, 2022–2025 78 TABLE 12 CASE STUDY 1: MENTEN AI LEVERAGED D-WAVE QUANTUM COMPUTING PRODUCTS TO BATTLE COVID-19 WITH QUANTUM PEPTIDE THERAPEUTICS 79 TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 80 TABLE 14 KEY BUYING CRITERIA FOR QUANTUM COMPUTING COMPONENTS 81 TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 84 TABLE 16 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 90 TABLE 17 QUANTUM COMPUTING IN HEALTHCARE SOFTWARE OFFERED BY KEY MARKET PLAYERS 91 TABLE 18 QUANTUM COMPUTING IN HEALTHCARE SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 91 TABLE 19 QUANTUM COMPUTING IN HEALTHCARE HARDWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 92 TABLE 20 QUANTUM COMPUTING IN HEALTHCARE SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 93 TABLE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 95 TABLE 22 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR ON-PREMISE SOLUTIONS, BY REGION, 2023–2030 (USD MILLION) 96 TABLE 23 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR CLOUD-BASED SOLUTIONS, BY REGION, 2023–2030 (USD MILLION) 97 TABLE 24 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 99 TABLE 25 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SUPERCONDUCTING QUBITS, BY REGION, 2023–2030 (USD MILLION) 100 TABLE 26 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR TRAPPED IONS, BY REGION, 2023–2030 (USD MILLION) 101 TABLE 27 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR QUANTUM ANNEALING, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 28 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR QUANTUM MACHINE LEARNING, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 29 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION) 104 TABLE 30 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 106 TABLE 31 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 32 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR MEDICAL DIAGNOSTICS APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR GENOMICS & PRECISION MEDICINE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RADIOTHERAPY APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RISK ANALYSIS APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 36 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE LOGISTICS & SCHEDULING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 37 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR CYBERSECURITY & DATA ENCRYPTION APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 38 QUANTUM COMPUTING IN HEALTHCARE MARKET OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 39 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION) 116 TABLE 40 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 41 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR LABS & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 42 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 43 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 44 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 45 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 46 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 124 TABLE 47 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 124 TABLE 48 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 125 TABLE 49 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125 TABLE 50 NORTH AMERICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 126 TABLE 51 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 127 TABLE 52 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 127 TABLE 53 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 127 TABLE 54 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 128 TABLE 55 US: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 128 TABLE 56 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 129 TABLE 57 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 130 TABLE 58 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 130 TABLE 59 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131 TABLE 60 CANADA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 131 TABLE 61 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 62 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 133 TABLE 63 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 133 TABLE 64 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 134 TABLE 65 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 134 TABLE 66 EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 135 TABLE 67 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 136 TABLE 68 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 136 TABLE 69 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 136 TABLE 70 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 137 TABLE 71 GERMANY: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 137 TABLE 72 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 138 TABLE 73 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 139 TABLE 74 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 139 TABLE 75 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140 TABLE 76 UK: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 77 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 141 TABLE 78 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 141 TABLE 79 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 142 TABLE 80 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 142 TABLE 81 FRANCE: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 143 TABLE 82 ITALY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 144 TABLE 83 ITALY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 144 TABLE 84 ITALY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 144 TABLE 85 ITALY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145 TABLE 86 ITALY: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 145 TABLE 87 SPAIN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 146 TABLE 88 SPAIN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 146 TABLE 89 SPAIN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 147 TABLE 90 SPAIN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147 TABLE 91 SPAIN: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 148 TABLE 92 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 148 TABLE 93 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 149 TABLE 94 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 149 TABLE 95 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 150 TABLE 96 REST OF EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 150 TABLE 97 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 98 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 153 TABLE 99 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 153 TABLE 100 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 154 TABLE 101 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 154 TABLE 102 ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 155 TABLE 103 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 156 TABLE 104 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 156 TABLE 105 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 156 TABLE 106 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 107 JAPAN: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 157 TABLE 108 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 158 TABLE 109 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 159 TABLE 110 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 159 TABLE 111 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160 TABLE 112 CHINA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 113 INDIA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 161 TABLE 114 INDIA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 162 TABLE 115 INDIA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 162 TABLE 116 INDIA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163 TABLE 117 INDIA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 118 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 164 TABLE 119 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 164 TABLE 120 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 165 TABLE 121 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 165 TABLE 122 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 123 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 124 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 167 TABLE 125 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 167 TABLE 126 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 168 TABLE 127 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 168 TABLE 128 LATIN AMERICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 129 BRAZIL: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 170 TABLE 130 BRAZIL: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 170 TABLE 131 BRAZIL: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 170 TABLE 132 BRAZIL: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 171 TABLE 133 BRAZIL: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 134 MEXICO: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 172 TABLE 135 MEXICO: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 172 TABLE 136 MEXICO: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 173 TABLE 137 MEXICO: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 173 TABLE 138 MEXICO: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 174 TABLE 139 REST OF LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 175 TABLE 140 REST OF LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 175 TABLE 141 REST OF LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 175 TABLE 142 REST OF LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 176 TABLE 143 REST OF LATIN AMERICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 144 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION, 2023–2030 (USD MILLION) 178 TABLE 145 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 178 TABLE 146 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 178 TABLE 147 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 179 TABLE 148 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 179 TABLE 149 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 180 TABLE 150 GCC COUNTRIES: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 180 TABLE 151 GCC COUNTRIES: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 181 TABLE 152 GCC COUNTRIES: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 181 TABLE 153 GCC COUNTRIES: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 182 TABLE 154 GCC COUNTRIES: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 155 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 183 TABLE 156 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 183 TABLE 157 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 184 TABLE 158 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 184 TABLE 159 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 160 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN QUANTUM COMPUTING IN HEALTHCARE, JANUARY 2022–MAY 2025 186 TABLE 161 QUANTUM COMPUTING IN HEALTHCARE MARKET: DEGREE OF COMPETITION 191 TABLE 162 QUANTUM COMPUTING IN HEALTHCARE MARKET: REGION FOOTPRINT 198 TABLE 163 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPONENT FOOTPRINT 199 TABLE 164 QUANTUM COMPUTING IN HEALTHCARE MARKET: APPLICATION FOOTPRINT 200 TABLE 165 QUANTUM COMPUTING IN HEALTHCARE MARKET: TECHNOLOGY FOOTPRINT 201 TABLE 166 QUANTUM COMPUTING IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT 202 TABLE 167 QUANTUM COMPUTING IN HEALTHCARE MARKET: END-USER FOOTPRINT 203 TABLE 168 QUANTUM COMPUTING IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 206 TABLE 169 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 206 TABLE 170 QUANTUM COMPUTING IN HEALTHCARE MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2022–MAY 2025 209 TABLE 171 QUANTUM COMPUTING IN HEALTHCARE MARKET: DEALS, JANUARY 2022–MAY 2025 210 TABLE 172 RIGETTI & CO, LLC.: COMPANY OVERVIEW 212 TABLE 173 RIGETTI & CO, LLC.: PRODUCTS & SERVICES OFFERED 213 TABLE 174 RIGETTI & CO, LLC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 214 TABLE 175 RIGETTI & CO, LLC.: DEALS, JANUARY 2022–MAY 2025 215 TABLE 176 RIGETTI & CO, LLC.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024 216 TABLE 177 IBM: COMPANY OVERVIEW 218 TABLE 178 IBM: PRODUCTS & SERVICES OFFERED 219 TABLE 179 IBM: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 220 TABLE 180 IBM: DEALS, JANUARY 2022–MAY 2025 220 TABLE 181 D-WAVE QUANTUM INC.: COMPANY OVERVIEW 222 TABLE 182 D-WAVE QUANTUM INC: PRODUCTS & SERVICES OFFERED 224 TABLE 183 D-WAVE QUANTUM INC: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 224 TABLE 184 D-WAVE QUANTUM INC.: DEALS, JANUARY 2022–MAY 2025 225 TABLE 185 MICROSOFT: COMPANY OVERVIEW 227 TABLE 186 MICROSOFT: PRODUCTS & SERVICES OFFERED 229 TABLE 187 MICROSOFT: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 229 TABLE 188 MICROSOFT: DEALS, JANUARY 2022–MAY 2025 230 TABLE 189 IONQ: COMPANY OVERVIEW 232 TABLE 190 IONQ: PRODUCTS & SERVICES OFFERED 233 TABLE 191 IONQ: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 234 TABLE 192 IONQ: DEALS, JANUARY 2022–MAY 2025 234 TABLE 193 QUANTINUUM LTD.: COMPANY OVERVIEW 236 TABLE 194 QUANTINUUM LTD.: PRODUCTS & SERVICES OFFERED 236 TABLE 195 QUANTINUUM LTD.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 237 TABLE 196 QUANTINUUM LTD.: DEALS, JANUARY 2022–MAY 2025 238 TABLE 197 GOOGLE LLC: COMPANY OVERVIEW 239 TABLE 198 GOOGLE LLC: PRODUCTS & SERVICES OFFERED 240 TABLE 199 GOOGLE LLC: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 241 TABLE 201 GOOGLE LLC: DEALS, JANUARY 2022–MAY 2025 242 TABLE 202 ATOS SE: COMPANY OVERVIEW 244 TABLE 203 ATOS SE: PRODUCTS & SERVICES OFFERED 245 TABLE 204 ATOS SE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 245 TABLE 205 ATOS SE: DEALS, JANUARY 2022–MAY 2025 246 TABLE 206 QC WARE: COMPANY OVERVIEW 247 TABLE 207 QC WARE: PRODUCTS & SERVICES OFFERED 247 TABLE 208 QC WARE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 248 TABLE 209 QC WARE: DEALS, JANUARY 2022–MAY 2025 248 TABLE 210 CLASSIQ TECHNOLOGIES LTD.: COMPANY OVERVIEW 249 TABLE 211 CLASSIQ TECHNOLOGIES LTD.: PRODUCTS & SERVICES OFFERED 249 TABLE 212 CLASSIQ TECHNOLOGIES LTD.: DEALS, JANUARY 2022–MAY 2025 250 TABLE 213 XANADU QUANTUM TECHNOLOGIES INC.: COMPANY OVERVIEW 252 TABLE 214 XANADU QUANTUM TECHNOLOGIES INC.: PRODUCTS & SERVICES OFFERED 252 TABLE 215 XANADU QUANTUM TECHNOLOGIES INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 253 TABLE 216 XANADU QUANTUM TECHNOLOGIES INC.: DEALS, JANUARY 2022–MAY 2025 254 TABLE 217 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 256 TABLE 218 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: PRODUCTS & SERVICES OFFERED 256 TABLE 219 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 257 TABLE 220 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: DEALS, JANUARY 2022–MAY 2025 258 TABLE 221 PROTIVITI INC.: COMPANY OVERVIEW 259 TABLE 222 PROTIVITI INC.: PRODUCTS & SERVICES OFFERED 260 TABLE 223 QUANDELA: COMPANY OVERVIEW 261 TABLE 224 QUANDELA: PRODUCTS & SERVICES OFFERED 261 TABLE 225 QUANDELA: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 262 TABLE 226 QUANDELA: DEALS, JANUARY 2022–MAY 2025 262 TABLE 227 DELOITTE: COMPANY OVERVIEW 264 TABLE 228 DELOITTE: PRODUCTS & SERVICES OFFERED 264 TABLE 229 DELOITTE: DEALS, JANUARY 2022–MAY 2025 265 TABLE 230 ACCENTURE: COMPANY OVERVIEW 266 TABLE 231 ACCENTURE: PRODUCTS & SERVICES OFFERED 267 TABLE 232 ACCENTURE: DEALS, JANUARY 2022–MAY 2025 268 TABLE 233 AMAZON WEB SERVICES (AWS): COMPANY OVERVIEW 269 TABLE 234 AMAZON WEB SERVICES (AWS): PRODUCTS & SERVICES OFFERED 270 TABLE 235 AMAZON WEB SERVICES (AWS): PRODUCT & SERVICE LAUNCHES, JANUARY 2022–MAY 2025 271 TABLE 236 AMAZON WEB SERVICES (AWS): DEALS, JANUARY 2022–MAY 2025 271 TABLE 237 FUJITSU: COMPANY OVERVIEW 273 TABLE 238 FUJITSU: PRODUCTS & SERVICES OFFERED 274 TABLE 239 FUJITSU: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 275 TABLE 240 FUJITSU: DEALS, JANUARY 2022–MAY 2025 276 TABLE 241 QNAMI: COMPANY OVERVIEW 277 TABLE 242 QNAMI: PRODUCTS & SERVICES OFFERED 277 TABLE 243 QNAMI: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 278 TABLE 244 QNAMI: DEALS, JANUARY 2022–MAY 2025 278 TABLE 245 QNAMI: EXPANSIONS, JANUARY 2022–MAY 2025 278 TABLE 246 SEEQC: COMPANY OVERVIEW 279 TABLE 247 SEEQC: PRODUCTS & SERVICES OFFERED 279 TABLE 248 SEEQC: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 280 TABLE 249 SEEQC: DEALS, JANUARY 2022–MAY 2025 280 FIGURE 1 QUANTUM COMPUTING IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE 29 FIGURE 2 RESEARCH DESIGN 33 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37 FIGURE 1 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 39 FIGURE 2 BOTTOM-UP APPROACH 40 FIGURE 3 TOP-DOWN APPROACH 41 FIGURE 4 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF QUANTUM COMPUTING IN HEALTHCARE INDUSTRY 42 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42 FIGURE 6 DATA TRIANGULATION METHODOLOGY 44 FIGURE 7 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2025 VS. 2030 (USD MILLION) 46 FIGURE 8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2025 VS. 2030 (USD MILLION) 47 FIGURE 9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 47 FIGURE 10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 48 FIGURE 11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 49 FIGURE 12 QUANTUM COMPUTING IN HEALTHCARE MARKET: REGIONAL SNAPSHOT 50 FIGURE 13 GOVERNMENT SUPPORT FOR ADOPTION OF QUANTUM COMPUTING TO DRIVE MARKET GROWTH 51 FIGURE 14 HARDWARE SEGMENT AND CHINA TO COMMAND LARGEST SHARES OF ASIA PACIFIC MARKET IN 2024 52 FIGURE 15 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 53 FIGURE 16 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 54 FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 54 FIGURE 18 QUANTUM COMPUTING IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 FIGURE 19 QUANTUM COMPUTING IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 69 FIGURE 20 QUANTUM COMPUTING IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS 74 FIGURE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET: ECOSYSTEM ANALYSIS 75 FIGURE 22 PATENT PUBLICATION TRENDS, JANUARY 2015–MAY 2025 76 FIGURE 23 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR QUANTUM COMPUTING IN HEALTHCARE MARKET, JANUARY 2012–MAY 2025 77 FIGURE 24 TOP APPLICANT COUNTRIES/JURISDICTIONS FOR QUANTUM COMPUTING IN HEALTHCARE PATENTS, JANUARY 2015–MAY 2025 78 FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 80 FIGURE 26 KEY BUYING CRITERIA FOR QUANTUM COMPUTING COMPONENTS 81 FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83 FIGURE 28 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET SNAPSHOT 123 FIGURE 29 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE SNAPSHOT 2024 152 FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN QUANTUM COMPUTING IN HEALTHCARE MARKET, 2020–2024 190 FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN QUANTUM COMPUTING IN HEALTHCARE MARKET, 2024 191 FIGURE 32 QUANTUM COMPUTING IN HEALTHCARE MARKET RANKING ANALYSIS, BY PLAYER, 2024 194 FIGURE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 196 FIGURE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY FOOTPRINT 197 FIGURE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 205 FIGURE 36 EV/EBITDA OF KEY VENDORS 207 FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 207 FIGURE 38 QUANTUM COMPUTING IN HEALTHCARE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 208 FIGURE 39 RIGETTI & CO, LLC.: COMPANY SNAPSHOT (2024) 213 FIGURE 40 IBM: COMPANY SNAPSHOT (2024) 219 FIGURE 41 D-WAVE QUANTUM INC.: COMPANY SNAPSHOT (2024) 223 FIGURE 42 MICROSOFT: COMPANY SNAPSHOT (2024) 228 FIGURE 43 IONQ: COMPANY SNAPSHOT (2024) 233 FIGURE 44 GOOGLE LLC: COMPANY SNAPSHOT (2024) 240 FIGURE 45 ATOS SE: COMPANY SNAPSHOT (2024) 244 FIGURE 46 PROTIVITI INC.: COMPANY SNAPSHOT (2024) 259 FIGURE 47 ACCENTURE: COMPANY SNAPSHOT (2024) 267 FIGURE 48 AMAZON WEB SERVICES (AWS): COMPANY SNAPSHOT (2024) 270 FIGURE 49 FUJITSU: COMPANY SNAPSHOT (2024) 274

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們